These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35212423)

  • 1. Improving adaptive seamless designs through Bayesian optimization.
    Richter J; Friede T; Rahnenführer J
    Biom J; 2022 Jun; 64(5):948-963. PubMed ID: 35212423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving clinical trials using Bayesian adaptive designs: a breast cancer example.
    Hong W; McLachlan SA; Moore M; Mahar RK
    BMC Med Res Methodol; 2022 May; 22(1):133. PubMed ID: 35508968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using dichotomized survival data to construct a prior distribution for a Bayesian seamless Phase II/III clinical trial.
    Duputel B; Stallard N; Montestruc F; Zohar S; Ursino M
    Stat Methods Med Res; 2023 May; 32(5):963-977. PubMed ID: 36919403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Bayesian sequential design with adaptive randomization for 2-sided hypothesis test.
    Yu Q; Zhu L; Zhu H
    Pharm Stat; 2017 Nov; 16(6):451-465. PubMed ID: 28980435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequentist operating characteristics of Bayesian optimal designs via simulation.
    Zhang Y; Trippa L; Parmigiani G
    Stat Med; 2019 Sep; 38(21):4026-4039. PubMed ID: 31215685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do we need to adjust for interim analyses in a Bayesian adaptive trial design?
    Ryan EG; Brock K; Gates S; Slade D
    BMC Med Res Methodol; 2020 Jun; 20(1):150. PubMed ID: 32522284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Stroke Hyperglycemia Insulin Network Effort (SHINE) trial: an adaptive trial design case study.
    Connor JT; Broglio KR; Durkalski V; Meurer WJ; Johnston KC
    Trials; 2015 Mar; 16():72. PubMed ID: 25885963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayesian decision-theoretic group sequential clinical trial design based on a quadratic loss function: a frequentist evaluation.
    Lewis RJ; Lipsky AM; Berry DA
    Clin Trials; 2007; 4(1):5-14. PubMed ID: 17327241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seamless phase 2/3 design for trials with multiple co-primary endpoints using Bayesian predictive power.
    Yang J; Li G; Yang D; Wu J; Wang J; Gao X; Liu P
    BMC Med Res Methodol; 2024 Jan; 24(1):12. PubMed ID: 38233758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods.
    Kimani PK; Glimm E; Maurer W; Hutton JL; Stallard N
    Stat Med; 2012 Aug; 31(19):2068-85. PubMed ID: 22437262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of clinical development pathways to advance tuberculosis regimen development.
    Chang V; Phillips PPJ; Imperial MZ; Nahid P; Savic RM
    BMC Infect Dis; 2022 Dec; 22(1):920. PubMed ID: 36494644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Bayesian decision-theoretic sequential response-adaptive randomization design.
    Jiang F; Jack Lee J; Müller P
    Stat Med; 2013 May; 32(12):1975-94. PubMed ID: 23315678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimized adaptive enrichment designs.
    Ondra T; Jobjörnsson S; Beckman RA; Burman CF; König F; Stallard N; Posch M
    Stat Methods Med Res; 2019 Jul; 28(7):2096-2111. PubMed ID: 29254436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Bayesian sequential design with binary outcome.
    Zhu H; Yu Q; Mercante DE
    Pharm Stat; 2017 May; 16(3):192-200. PubMed ID: 28251815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Bayesian comparative effectiveness trial in action: developing a platform for multisite study adaptive randomization.
    Brown AR; Gajewski BJ; Aaronson LS; Mudaranthakam DP; Hunt SL; Berry SM; Quintana M; Pasnoor M; Dimachkie MM; Jawdat O; Herbelin L; Barohn RJ
    Trials; 2016 Aug; 17(1):428. PubMed ID: 27577191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.
    Meinzer C; Martin R; Suarez JI
    Trials; 2017 Sep; 18(1):420. PubMed ID: 28886745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal adaptive promising zone designs.
    Mehta C; Bhingare A; Liu L; Senchaudhuri P
    Stat Med; 2022 May; 41(11):1950-1970. PubMed ID: 35165917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Sample Size Allocation and Power in a Bayesian Two-Stage Drop-The-Losers Design.
    Karanevich A; Meier R; Graw S; McGlothlin A; Gajewski B
    Am Stat; 2019; 2019():. PubMed ID: 32981939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bayesian adaptive randomization designs for targeted agent development.
    Lee JJ; Xuemin Gu ; Suyu Liu
    Clin Trials; 2010 Oct; 7(5):584-96. PubMed ID: 20571130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using Bayesian Adaptive Trial Designs for Comparative Effectiveness Research: A Virtual Trial Execution.
    Luce BR; Connor JT; Broglio KR; Mullins CD; Ishak KJ; Saunders E; Davis BR;
    Ann Intern Med; 2016 Sep; 165(6):431-8. PubMed ID: 27273013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.